Drug Updates

ICL Joins Forces with PlantArcBio to Boost Crop Yields

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and ag-biotech company PlantArcBio, Ltd. (TASE: PLNT), today announced the development of a novel bio-stimulant technology platform, which will improve crop yields while having minimal impact on the environment.  The platform successfully uses of RNAi technology to maximize a plant’s natural yield increase mechanisms, without […]